Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0055 | 0.0202 | 0.0641 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0068 | 0.0294 | 0.0874 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.021 | 0.1303 | 0.1353 |
Brugia malayi | RNA binding protein | 0.047 | 0.3152 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.0195 | 0.0618 |
Brugia malayi | Pre-SET motif family protein | 0.003 | 0.0023 | 0.0008 |
Brugia malayi | Pre-SET motif family protein | 0.0208 | 0.1287 | 0.4044 |
Brugia malayi | MH2 domain containing protein | 0.0369 | 0.2432 | 0.77 |
Loa Loa (eye worm) | RNA binding protein | 0.047 | 0.3152 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0208 | 0.1287 | 0.4083 |
Loa Loa (eye worm) | intermediate filament protein | 0.0055 | 0.0202 | 0.0641 |
Brugia malayi | RNA recognition motif domain containing protein | 0.047 | 0.3152 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.0294 | 0.0287 |
Echinococcus multilocularis | musashi | 0.0055 | 0.0202 | 0.0202 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0068 | 0.0294 | 0.0294 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0215 | 0.1337 | 0.4242 |
Echinococcus multilocularis | histone lysine methyltransferase setb histone lysine methyltransferase eggless | 0.003 | 0.0023 | 0.0023 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.1361 | 0.9481 | 0.9481 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0068 | 0.0294 | 0.0934 |
Echinococcus granulosus | microtubule associated protein 2 | 0.1361 | 0.9481 | 0.9481 |
Schistosoma mansoni | tar DNA-binding protein | 0.047 | 0.3152 | 0.3309 |
Loa Loa (eye worm) | hypothetical protein | 0.021 | 0.1303 | 0.4133 |
Loa Loa (eye worm) | hypothetical protein | 0.0147 | 0.0855 | 0.2711 |
Onchocerca volvulus | 0.0055 | 0.0202 | 0.1217 | |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0068 | 0.0294 | 0.0294 |
Schistosoma mansoni | tar DNA-binding protein | 0.047 | 0.3152 | 0.3309 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.0294 | 0.0934 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.0294 | 0.0287 |
Schistosoma mansoni | tar DNA-binding protein | 0.047 | 0.3152 | 0.3309 |
Onchocerca volvulus | 0.021 | 0.1303 | 0.8719 | |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0068 | 0.0294 | 0.0874 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0023 | 0.0074 |
Echinococcus multilocularis | lamin dm0 | 0.0055 | 0.0202 | 0.0202 |
Onchocerca volvulus | 0.0055 | 0.0202 | 0.1217 | |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0068 | 0.0294 | 0.0294 |
Schistosoma mansoni | hypothetical protein | 0.0147 | 0.0855 | 0.0879 |
Echinococcus granulosus | intermediate filament protein | 0.0055 | 0.0202 | 0.0202 |
Echinococcus granulosus | tar DNA binding protein | 0.047 | 0.3152 | 0.3152 |
Schistosoma mansoni | lamin | 0.0055 | 0.0202 | 0.0189 |
Echinococcus multilocularis | tumor protein p63 | 0.1434 | 1 | 1 |
Onchocerca volvulus | 0.0236 | 0.1491 | 1 | |
Echinococcus multilocularis | GPCR, family 2 | 0.0068 | 0.0294 | 0.0294 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0055 | 0.0202 | 0.0579 |
Loa Loa (eye worm) | TAR-binding protein | 0.047 | 0.3152 | 1 |
Plasmodium vivax | SET domain protein, putative | 0.003 | 0.0023 | 0.5 |
Echinococcus granulosus | lamin dm0 | 0.0055 | 0.0202 | 0.0202 |
Echinococcus multilocularis | lamin | 0.0055 | 0.0202 | 0.0202 |
Echinococcus multilocularis | histone lysine N methyltransferase SETMAR | 0.003 | 0.0023 | 0.0023 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0369 | 0.2432 | 0.7715 |
Echinococcus granulosus | lamin | 0.0055 | 0.0202 | 0.0202 |
Loa Loa (eye worm) | hypothetical protein | 0.0215 | 0.1337 | 0.4242 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0147 | 0.0855 | 0.2663 |
Trichomonas vaginalis | set domain proteins, putative | 0.0236 | 0.1491 | 0.5 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0029 | 0.0021 | 0.0066 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.003 | 0.0023 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0068 | 0.0294 | 0.0294 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.003 | 0.0023 | 0.0023 |
Schistosoma mansoni | tar DNA-binding protein | 0.047 | 0.3152 | 0.3309 |
Schistosoma mansoni | lamin | 0.0055 | 0.0202 | 0.0189 |
Echinococcus multilocularis | tar DNA binding protein | 0.047 | 0.3152 | 0.3152 |
Schistosoma mansoni | tar DNA-binding protein | 0.047 | 0.3152 | 0.3309 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0369 | 0.2432 | 0.7715 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0215 | 0.1337 | 0.4204 |
Schistosoma mansoni | microtubule-associated protein tau | 0.1361 | 0.9481 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0215 | 0.1337 | 0.4204 |
Brugia malayi | intermediate filament protein | 0.0055 | 0.0202 | 0.0579 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0202 | 0.0641 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.047 | 0.3152 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.0294 | 0.0287 |
Schistosoma mansoni | intermediate filament proteins | 0.0055 | 0.0202 | 0.0189 |
Brugia malayi | TAR-binding protein | 0.047 | 0.3152 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0068 | 0.0294 | 0.0294 |
Schistosoma mansoni | hypothetical protein | 0.0068 | 0.0294 | 0.0287 |
Echinococcus granulosus | 5'partial|histone lysine N methyltransferase SETDB2 | 0.0029 | 0.0015 | 0.0015 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.